Effects of the nootropic drug nefiracetam on the GABA(A) receptor-channel complex in dorsal root ganglion neurons

Neuropharmacology

Volumn 35, Issue 9-10, 1996, Pages 1251-1261

  Huang, Chao Sheng ^a   Ma, Jenny Yan ^b   Marszalec, W ^a   Narahashi, T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Desensitization; G proteins; GABA receptor channel; Nefiracetam; Nootropic drug; Protein kinase A

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; CHLORIDE CHANNEL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; KT 5720; NEFIRACETAM; NOOTROPIC AGENT; PERTUSSIS TOXIN;

ANIMAL CELL; ARTICLE; CHLORIDE CURRENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESENSITIZATION; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; NERVE CELL CULTURE; NEUROMODULATION; NEWBORN; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPINAL GANGLION; SYNAPTIC TRANSMISSION;

ANIMALS; CHLORIDE CHANNELS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; GAMMA-AMINOBUTYRIC ACID; GANGLIA, SPINAL; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; MEMBRANE POTENTIALS; NEURONS; NOOTROPIC AGENTS; PATCH-CLAMP TECHNIQUES; PROTEIN KINASES; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SYNAPTIC TRANSMISSION;

EID: 0030444046     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(96)00074-3     Document Type: Article

References (36)

1. Arneric S.P., Sulliva J.P., Briggs C.A., Donnelly-Roberts D., Anderson D.J., Raszkiewicz J.L., Hughes M.L., Cadman E.D., Adams P., Garvey D.S., Wasicak J.T., Williams M. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities. In vitro characterization J. Pharmacol. Exp. Ther. 270:1994;310-318.
2. Copani A., Genazzani A.A., Aleppo G., Casabona G., Canonico P.L., Scapagnini V., Nicoletti F. Nootropic drugs positively modulate α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid-sensitive glutamate receptors in neuronal cultures. J. Neurochem. 58:1992;1199-1204.
3. Fenwick E.M., Marty A., Neher E. A patch-clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine. J. Physiol. 331:1982;577-597.
4. Frosch M.P., Lipton S.A., Dichter M.A. Desensitization of GABA-activated currents and channels in cultured cortical neurons. J. Neurosci. 12:1992;3042-3053.
5. Funk K.F., Schmidt J. Changes of dopamine metabolism by hypoxia and effect of nootropic drugs. Biomed. Biochem. Acta. 11:1984;1301-1304.
6. Garvey D.S., Wasicak J., Decker M.W., Brioni J.D., Buckley M.J., Sullivan J.P., Carrera G.M., Holladay M.H., Arneric S.P., Williams M. Novel isoxazoles which interact with brain cholinergic channel receptors that have intrinsic cognitive enhancing and anxiolytic activities. J. Med. Chem. 37:1994;1055-1059.
7. Giurgea C.E. The nootropic concept and its prospective implications. Drug Dev. Res. 2:1982;441-446.
8. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch clamp technique for high-solution current recording from cells and cell-free membrane patches. Pflügers Arch. 391:1981;85-100.
9. Hansen G.H., Meier E., Schousboe A. GABA influences the ultrastructure composition of cerebellar granule cells during development in culture. Int. J. Dev. Neurosci. 2:1984;247-257.
10. Hara C. and Ogawa N. (1989) Characterization of learning deficit induced by ibotenic acid lesion of the frontal cortex in rats, paper presented at Alzheimer's and Parkinson's Diseases: The 2nd International Conference, Kyoto.
11. Huang C.S., Narahashi T. Protein kinase A is involved in mercury chloride potentiation of GABA-activated chloride currents in rat dorsal root ganglion neurons. Soc. Neurosci. Abstr. 21:1995;55.
12. Isaascon J.S., Nicoll R.A. Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus. Proc. Natn. Acad. Sci. U.S.A. 188:1991;10936-10940.
13. Ito I., Tanabe S., Kohda A., Sugiyama H. Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J. Physiol. 424:1990;533-543.
14. Kameyama T., Nabeshima T., Tohyama K., Shiotani T. Protective effects of DM-9384, a pyrrolidone derivative, on cyclohexamide-induced decrease of GABA and acetylcholine receptors. Soc. Neurosci. Abstr. 15:1989;1174.
15. Kawajiri S., Sakurai T., and Ojima H. (1988) Effect of DM-9384, a new pyrrolidone derivative, on learning behavior and cerebral choline acetyltransferase activity in rats. Psychopharmacology 96 Suppl. Abstr. 32. 02. 24.
16. Kawajiri S., Taniguchi K., Sakurai T. Effect of DM-9384 on extracellular acetylcholine in the rat frontal cortex measured with microdialysis. Eur. J. Pharmacol. 193:1990;928.
17. Krishtal O.A., Pidophlichko V.I. A receptor for protons in the nerve cell membrane. Neuroscience. 5:1980;2325-2327.
18. A receptor-channel complex by polyvalent cations in rat root ganglion neurons. Brain Res. 607:1993;222-232.
19. Marchi M., Besana E., Raiteri M. Oxiracetam increases the release of endogenous glutamate from depolarized rat hippocampal slices. Eur. J. Pharmacol. 185:1990;247-249.
20. Meier E., Jorgensen O.S., Schousboe A. Effect of repeated treatment with a GABA receptor agonist on postnatal neural development in rats. J. Neurochem. 49:1987;1462-1470.
21. Meier E., Hertz L., Schousboe A. Neurotransmitters as developmental signals. Neurochem. Int. 19:1991;1-15.
22. A receptors by cAMP-dependent protein phosphorylation. Science. 257:1992;661-665.
23. Murashima Y.L. Furni Y., Shinozaki T., Watabe S. and Yoshii M. (1991) DM-9384, a cyclic GABA derivative, elevates the cAMP level in NG108-15 cells. Neurosci. Res. Suppl. 16: S60.
24. Nabeshima T. Ameliorating effects of nefiracetam (DM-9384) on brain dysfunction. Drugs of Today. 30:1994;357-379.
25. A and muscarinic receptors induced by cycloheximide. J. Pharmacol. Exp. Ther. 257:1991;271-275.
26. A receptor current in mouse spinal neurons. Neuron. 5:1990;789-796.
27. Sakurai T., Ojima H., Yamasaki T., Kojima H., Akashi A. Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide (DM-9384) on learning and memory in rats. Japan. J. Pharmacol. 50:1989;47-53.
28. Sarter M. Taking stock of cognition enhancers. Trends Pharmacol. Sci. 12:1991;456-461.
29. Satoh M., Ishihara K., Iwama T., Takagi H. Aniracetam augments, and midazolam inhibits, the long-term potentiation in guinea-pig hippocampal slices. Neurosci. Lett. 68:1986;216-220.
30. Sternweis P.C., Pang I.-H. The G protein-channel connection. Trends Neurosci. 13:1990;122-126.
31. Tang C.-M., Shi Q.-Y., Katchman A., Lynch G. Modulation of the time course of fast EPSCs and glutamate channel kinetics by aniracetam. Science. 254:1991;288-290.
32. Tewari S., Baxter C.F. Stimulatory effect of GABA upon amino acid incorporation into protein by a ribosomal system from immature brain. J. Neurochem. 16:1969;171-180.
33. Tohyama K., Nebeshima T. and Kameyama T. (1988) Effect of DM-9384, a pyrrolidone derivative, on benzodiazepine-induced amnesia. Psychopharmacology 96 Suppl. Abstr. 32. 02. 23.
34. Watabe S., Yoshii M. Ion channels and cognitive enhancers. Japan. J. Neuropharmacol. 15:1993;249-257.
35. Watabe S., Yamaguchi H., Ashida S. DM-9384, a new cognition-enhancing agent, increases the turnover of components of the GABAergic system in the rat cerebral cortex. Eur. J. Pharmacol. 238:1993;303-309.
36. Yoshii M., Watabe S. Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells. Brain Res. 642:1994;123-131.